Navigation Links
Snail venom Found To Ease Pain In Cancer Victims

Laboratory research has found evidence that the venom that the snails inject to immobilize their prey might have beneficial effects // on some heart problems, strokes, central nervous system disorders and other ills.
The latest study involved the experimental drug ziconotide, a laboratory-made equivalent of a compound in the venom of the small Conus Magus cone snail, which lives in shallow tropical saltwater.

The snail-venom research involved 111 patients ages 24 to 85 in the United States, Australia and the Netherlands. All were treated with a small, battery-operated pump implanted in their abdomens and attached to a catheter that delivered continuous medication or a dummy drug into fluid surrounding the spinal cord. Treatment lasted about 10 days; most patients were not hospitalized during that time.

The infusions produced significant relief in patients whose pain did not respond to more conventional drugs such as morphine.Pain relief was moderate to complete in 53 percent of ziconotide patients, compared with about 18 percent of the placebo group.

Serious side effects occurred in 22 ziconotide patients and four placebo patients. Subsequent research has shown that starting patients on lower doses reduces the risks, and many have remained on treatment for more than a year.

Specialists feel this new, promising kind of treatment could relieve thousands of cancer patients who suffer from intractable pain and who don't respond to the normal, conventional treatments.

Federal approval for the drug is still being sought and researchers say they expect it to become commercially available within the year.
'"/>




Page: 1

Related medicine news :

1. Painkiller Based on Sea Snail Venom Made Available in Britain
2. Venomous Cone Snails Relieve Chronic Back Pain
3. Health Benefits from the Ocean Snail
4. A New Target for Painkillers: Snail Toxins Show the Way
5. Sea Snails May Aid Chronic Pain Treatments – Says Researcher
6. Snake venom a treatment for digestive disease
7. Fluoride Found Effective in Osteoporosis
8. Implantable Contact Lens Found Safe and Effective
9. Cancer hazard Found With Animal-Based Nutrients
10. Processed Meat, Diabetes connection Found
11. Night Time Aspirin Regimen Found to Reduce Blood Pressure

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Snail venom Found Ease Pain Cancer Victims

(Date:11/27/2009)..., , NEUILLY-SUR-SEINE, France, Nov. 27 /...merican professional cycling team dedicated to eth...f cycling champions, announced today that it will ...f Transitions Optical as a new sponsor of the team...acturer of adaptive eyewear, offering the most adv...
(Date:11/27/2009)...Soaring rates to bring unprecedented medical, econ... Nov. 27 (HealthDay News) -- The number of people ...double over the next 25 years, a new study predict...t 44.1 million people with the disease, up from 23... of treating people with diabetes will triple, the...
(Date:11/27/2009)... Specialist manufacturers...products are saving millions of dollars by bringin...n process. Increasing numbers of pro-active medica...xperts at the concept stage of their projects, ens...sting design processes or potentially outdated tec...
(Date:11/26/2009)... In the next 25 years, the number of Americans li...from 23.7 million in 2009 to 44.1 million in 2034....lmost triple, rising from $113 billion to $336 bil...besity, researchers based at the University of Chi...e . , The number of those with diabetes covered ...
(Date:11/26/2009)... No more letters from the...r,personalized text messages from Santa , ...ffort to increase operational efficiencies at the ...g to help keep children all over the globe informe...,Elves in Santa’s research department have i...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...r General criticized the medical system in the Ind...arry out medical relief //services in the event of...mplied after auditing important installations of t...s hospitals were ill-equipped due to non-availabil...
...n have satellite-based educational facilities to e... - Tripura, Mizoram and Nagaland - will be include...ng the services of EDUSAT, a dedicated satellite f...te schools. "Educational programmes through ...
...have become a way of life in Nepal's schools with ...me of combating Maoist guerrillas, say child right...ce, an umbrella of 36 rights organisations, says i... "Now there is a democratic government that say...
...ICEF have renewed their international partnership ...ey will support// the global campaign on HIV/AIDS ...e two bodies will also promote the right of all ch...gional office for South Asia and the ACC, which re...
...likely to live long, research suggests.Two researc...ging// told at the Chicago Actuarial Association m... has a major impact on how long her child will liv...ild born to a woman below the age of 25 years. Th...
... and Dementia could be reversed only by early diag...proves by diagnosing the underlying causes and ini... What you don’t know about Alzheimer’s disease cou...rning signs of Alzheimer’s disease: Increasing...
Other Medicine News:Health News:India's Northeast Students to Get Satellite-based Education Soon 2Health News:Girl Students Sexually Harassed by Security Forces in Nepal 2
(Date:11/25/2009)...inker.comannouncesthatanewmarketresearchreportisav...ry-USMarketTrends&Analysis http://www.reportl...arket-Trends--Analysis.html ,, TheUSintranasal...uticapplicationsfromthedeliveryofconventionallocal...drugs.Thefutureofthetechnologyhingesontotheeffecti...
(Date:11/25/2009)... Nov. 25 HeartWare Inter...ng innovator and provider of less invasive, miniat...izing the treatment of advanced heart failure, tod...tor presentation at the 21st Annual Piper Jaffray ..., December 2, 2009. The conference is being held a...
(Date:11/24/2009)... /PRNewswire-Asia/ -- Chindex International, Inc.,...t American provider of Western,healthcare products...oday,announced that the Company will attend the 21...nference, to be held December 1 - 2, 2009, at the,...rrently scheduled to present at 11:30 am ET on Tue...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2Chindex International to Present at Piper Jaffray Health Care Conference 2Beth Shulte joins Navvis 26amp 3B Company 54009 1Beth Shulte joins Navvis 26amp 3B Company 54009 2Young early stage ovarian cancer patients can preserve fertility 54007 1Young early stage ovarian cancer patients can preserve fertility 54007 2WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting 13461 1WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting 13461 2
...al trial to study Prasugrel against Clopidogrel...IANAPOLIS, June 23 Daiichi,Sankyo Company, Limite...Y ),said that the U.S. Food and Drug Administratio...sugrel new drug application (NDA) based on,supplem...d. This three,month extension allows the FDA time ...
...ignificantly higher inciden... Therapeutics,Inc. (Nasdaq: CVTX ) today announce... results of a major study demonstrating that one i... year after a myocardial infarction (MI),or heart ...ignificantly,elevated rates of depression among ca...
Other Medicine Technology:FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 2FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 3FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 4CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year 2CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year 3CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year 4
Kratz-Barraquer Eye Speculum - Pediatric
Kratz-Nichamin Speculum
Barraquer Eye Speculum
Wiener Eye Speculum
Medicine Products: